Company: SOS
Filing Date: 2025-06-25
Form Type: F-3/A
Source: 0001213900-25-057886
Chunk: 104

Company: SOS Ltd
Filing Date: 2025-06-25
Form: F-3/A
Chunk 104
---
 reflecting stock dividends and splits or other
similar transactions, and full ratchet anti-dilution protection with respect to the issuance of ordinary shares or ordinary share equivalents
for consideration per share less than the initial exercise price of the Warrants. The Warrants contain a mandatory exercise right for
the Company to force exercise of the Warrants if the Company’s Shares trades at or above $0.197295 per Share, for 20 consecutive
trading days, provided, among other things, that the shares issuable upon exercise of the Warrants are registered or may be sold pursuant
to Rule 144 and the daily trading volume exceeds 300,000 Shares per trading day on each trading day in a period of 20 consecutive trading
days prior to the applicable date.

The parties to the SPA have each made customary
representations, warranties and covenants, including, among other things, (a) the Selling Shareholders are “non-U.S. Persons”
as defined in Regulation S and are acquiring the Shares for the purpose of investment, (d) the absence of any undisclosed material adverse
effects, and (e) the absence of legal proceedings that affect the completion of the transaction contemplated by the SPA.

On June 19, 2024, the transaction contemplated
by the SPA consummated and the Warrants were issued to the Selling Shareholders.

The forms of the SPA and the Warrant are filed
as Exhibits 99.1 and 99.2, respectively, to the Current Report on Form 6-K, dated June 12, 2024 and such documents are incorporated herein
by reference. The foregoing is only a brief description of the material terms of the SPA and Warrant, and does not purport to be a complete
description of the rights and obligations of the parties thereunder and is qualified in its entirety by reference to such exhibits.

<div align='center'>62

PLAN OF DISTRIBUTION OF SELLING SECURITYHOLDERS</div>

The Selling Securityholders
and any of its pledgees, donees, transferees, assignees and successors-in-interest may, from time to time, sell any or all of their Resale
Shares, in the form of ADSs, on the NYSE or any other securities exchange, market or trading facility on which shares of our ADSs are
traded or in private transactions. These sales may be at fixed or negotiated prices. The Selling Securityholders may use any one or more
of the following methods when selling